Prognostic, predictive, and pharmacogenomic assessments of CDX 2 refine stratification of colorectal cancer-Reference-Cited by-同舟云学术

Prognostic, predictive, and pharmacogenomic assessments of CDX 2 refine stratification of colorectal cancer

Published:2018-08-15 Issue:9 Volume:12 Page:1639-1655
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Bruun Jarle¹²,Sveen Anita¹²,Barros Rita³⁴⁵,Eide Peter W.¹²,Eilertsen Ina¹²,Kolberg Matthias¹²^ORCID,Pellinen Teijo⁶,David Leonor³⁴⁵,Svindland Aud²⁷⁸,Kallioniemi Olli⁶⁹¹⁰,Guren Marianne G.²¹¹,Nesbakken Arild²⁷¹²,Almeida Raquel³⁴⁵¹³,Lothe Ragnhild A.¹²⁷

Affiliation:

1. Department of Molecular Oncology Institute for Cancer Research the Norwegian Radium Hospital Oslo University Hospital Norway

2. K.G. Jebsen Colorectal Cancer Research Centre Clinic for Cancer Medicine Oslo University Hospital Norway

3. Institute of Molecular Pathology and Immunology University of Porto (IPATIMUP) Portugal

4. Instituto de Investigação e InovaçãoemSaúde (i3S) Porto Portugal

5. Faculty of Medicine University of Porto Portugal

6. Institute for Molecular Medicine Finland (FIMM) University of Helsinki Finland

7. Institute for Clinical Medicine Faculty of Medicine University of Oslo Norway

8. Department of Pathology Oslo University Hospital Norway

9. Science for Life Laboratory Solna Sweden

10. Department of Oncology and Pathology Karolinska Institutet Solna Sweden

11. Department of Oncology Oslo University Hospital Norway

12. Department of Gastrointestinal Surgery Aker Hospital – Oslo University Hospital Norway

13. Biology Department Faculty of Sciences University of Porto Portugal

Funder

Kreftforeningen

Stiftelsen Kristian Gerhard Jebsen

Norges Forskningsråd

Universitetet i Oslo

European Regional Development Fund

Fuel Cycle Technologies

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12347

Reference50 articles.

1. Epigenetic and genetic features of 24 colon cancer cell lines

2. Prognostic and predictive factors in breast cancer by immunohistochemical analysis;Allred DC;Mod Pathol,1998

3. Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer

4. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients

5. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical analysis of cdx2 and its correlation with histopathological parameters of gastric enteric and colorectal epithelial malignancies;IP Journal of Diagnostic Pathology and Oncology;2024-01-15

2. Machine-Learning Identifies a Strategy for Differentiation Therapy in Solid Tumors;2023-09-17

3. Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer;Cancer Medicine;2023-08-21

4. Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer;Pathology and Oncology Research;2023-05-31

5. CDX2-positive Cancer of Unknown Primary With Upper-body Paralysis Was Dramatically Improved by Colorectal Cancer Chemotherapy;Anticancer Research;2023-05-29